Tag: biomedicines
ABIONYX Pharma announces positive clinical results for CER-001 in the treatment of COVID-19, published in the journal Biomedicines, demonstrating that CER-001 limits the effects of inflammation – 03/24/2022 at 18:00
Improved reverse cholesterol transport Reduction of inflammatory markers and cytokines A treatment option for patients with COVID-19 Toulouse, FRANCE, Lakeland, UNITED STATES, March 24, 2022, 6:00 p.m. – ABIONYX Pharma,…
In the battle between biosimilars and biomedicines, the Ministry of Health seeks a consensus
Aurel It is a hushed war that has agitated the pharmaceutical industry for more than a decade. Fifteen years after their arrival in France, biosimilars – these almost identical copies…